Prestige Wealth Management Group LLC Biomarin Pharmaceutical Inc Transaction History
Prestige Wealth Management Group LLC
- $460 Million
- Q3 2024
A detailed history of Prestige Wealth Management Group LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 59 shares of BMRN stock, worth $3,931. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59
Previous 34
73.53%
Holding current value
$3,931
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding BMRN
# of Institutions
637Shares Held
177MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.52 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.28 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.26 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$926 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$699 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.4B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...